Combination therapy for kidney disease in people with diabetes mellitus-Reference-Cited by-同舟云学术

Combination therapy for kidney disease in people with diabetes mellitus

Published:2024-04-03 Issue:7 Volume:20 Page:433-446
ISSN:1759-5061
Container-title:Nature Reviews Nephrology
language:en
Short-container-title:Nat Rev Nephrol

Author:

van Raalte Daniël H.,Bjornstad Petter,Cherney David Z. I.^ORCID,de Boer Ian H.,Fioretto Paola^ORCID,Gordin Daniel,Persson Frederik^ORCID,Rosas Sylvia E.^ORCID,Rossing Peter^ORCID,Schaub Jennifer A.^ORCID,Tuttle Katherine^ORCID,Waikar Sushrut S.^ORCID,Heerspink Hiddo J. L.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41581-024-00827-z.pdf

Reference152 articles.

1. de Boer, I. H. et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 305, 2532–2539 (2011).

2. de Boer, I. H., Group DER. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 37, 24–30 (2014).

3. Afkarian, M. et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA 316, 602–610 (2016).

4. Koye, D. N., Magliano, D. J., Nelson, R. G. & Pavkov, M. E. The global epidemiology of diabetes and kidney disease. Adv. Chronic Kidney Dis. 25, 121–132 (2018).

5. Agrawal, L. et al. Intensive glycemic control improves long-term renal outcomes in type 2 diabetes in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care 42, e181–e182 (2019).

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelin Receptor Antagonists Plus Sodium-Glucose Cotransporter 2 Inhibitors;Journal of the American Society of Nephrology;2024-09-04

2. Bridging the Gap Between CKD Management Paradigms in Transplant and Nontransplant Settings: Published Evidence, Challenges, and Perspectives;Transplantation;2024-08-29

3. Podocyte Death in Diabetic Kidney Disease: Potential Molecular Mechanisms and Therapeutic Targets;International Journal of Molecular Sciences;2024-08-20

4. An oral hypoglycemic agent for T2DM with the function of alleviating multi-complications;2024-08-05

5. Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors;Nature Reviews Nephrology;2024-07-22